Administration of Tissue Plasminogen Activator (tPA) During an Orthotopic Heart Transplant

The Internet Journal of Anesthesiology
doi 10.5580/686
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Internet Scientific Publishers, LLC

Related search

Tissue Plasminogen Activator (tPA) as Therapy for Hepatotoxicity Following Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1999English

Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (R-Tpa) in Acute Ischemic Stroke

Jentashapir Journal of Health Research
2016English

Decreased Serotonin Levels Associated With Behavioral Disinhibition in Tissue Plasminogen Activator Deficient (tPA−/−) Mice

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2010English

Conformations of Tissue Plasminogen Activator (tPA) Orchestrate Neuronal Survival by a Crosstalk Between EGFR and NMDAR

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Deletion of the Alu Repeat in the Tissue Plasminogen Activator (tPA) Gene for Protection of Breast Cancer

International Journal of Cancer Research
Cancer ResearchOncology
2018English

Frequency of Stroke Patients Qualified for Recombinant Tissue Plasminogen Activator (R-Tpa) and Constraints in Zahedan 2016

International Journal of Basic & Clinical Pharmacology
2017English

Mechanical Clot Disruption Following Intravenous Recombinant Tissue Plasminogen Activator Administration in Non-Responders

Neurologia Medico-Chirurgica
SurgeryNeurology
2010English

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke

Case Reports in Critical Care
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy